Clopidogrel how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Clopidogrel}} {{CMG}}; {{AE}} {{JH}} ==Title== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PLAVIX (CLOPIDOGREL BISULFATE) TABLE...")
 
mNo edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{JH}}
{{CMG}}; {{AE}} {{JH}}


==Title==
==How Supplied/Storage And Handling==


Plavix (clopidogrel bisulfate) 75 mg tablets are available as pink, round, biconvex, film-coated tablets debossed with "75" on one side and "1171" on the other. Tablets are provided as follows:


NDC 63653-1171-6        Bottles of 30


<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01b14603-8f29-4fa3-8d7e-9d523f802e0b | publisher =  | date =  | accessdate = }}</ref>
NDC 63653-1171-1        Bottles of 90
 
NDC 63653-1171-5        Bottles of 500
 
NDC 63653-1171-3        Blisters of 100
 
Plavix (clopidogrel bisulfate) 300 mg tablets are available as pink, oblong, film-coated tablets debossed with "300" on one side and "1332" on the other. Tablets are provided as follows:
 
NDC 63653-1332-2        Unit-dose packages of 30
 
NDC 63653-1332-3        Unit-dose packages of 100
 
Store at 25° C (77° F); excursions permitted to 15°–30° C (59°–86° F) [see USP Controlled Room Temperature].<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01b14603-8f29-4fa3-8d7e-9d523f802e0b | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==

Revision as of 17:05, 6 March 2014

Clopidogrel
PLAVIX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Clopidogrel
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

How Supplied/Storage And Handling

Plavix (clopidogrel bisulfate) 75 mg tablets are available as pink, round, biconvex, film-coated tablets debossed with "75" on one side and "1171" on the other. Tablets are provided as follows:

NDC 63653-1171-6 Bottles of 30

NDC 63653-1171-1 Bottles of 90

NDC 63653-1171-5 Bottles of 500

NDC 63653-1171-3 Blisters of 100

Plavix (clopidogrel bisulfate) 300 mg tablets are available as pink, oblong, film-coated tablets debossed with "300" on one side and "1332" on the other. Tablets are provided as follows:

NDC 63653-1332-2 Unit-dose packages of 30

NDC 63653-1332-3 Unit-dose packages of 100

Store at 25° C (77° F); excursions permitted to 15°–30° C (59°–86° F) [see USP Controlled Room Temperature].[1]

References

  1. "PLAVIX (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [BRISTOL-MYERS SQUIBB/SANOFI PHARMACEUTICALS PARTNERSHIP]".

Adapted from the FDA Package Insert.